|
Re: Hepalink
|
3
|
Resverlogix Corp.
|
Feb 21, 2020 02:27PM
|
|
Re: Hepalink
|
2
|
Resverlogix Corp.
|
Feb 21, 2020 03:19PM
|
|
Re: Hepalink
|
2
|
Resverlogix Corp.
|
Feb 21, 2020 04:03PM
|
|
Re: Hepa Mystery???
|
1
|
Resverlogix Corp.
|
Jul 10, 2016 08:40PM
|
|
Re: Hepa Mystery???
|
3
|
Resverlogix Corp.
|
Jul 10, 2016 04:08PM
|
|
Re: Help on Short Interest Please
|
2
|
Resverlogix Corp.
|
Mar 07, 2019 01:58PM
|
|
Re: Hedge Knight Capital Discussion
|
9
|
Resverlogix Corp.
|
May 28, 2019 04:42PM
|
|
Re: Hedge Knight Capital Discussion
|
2
|
Resverlogix Corp.
|
May 26, 2019 09:12AM
|
|
Re: Hedge Knight Capital Discussion
|
4
|
Resverlogix Corp.
|
May 26, 2019 04:54PM
|
|
Re: Hedge Knight Capital Discussion
|
3
|
Resverlogix Corp.
|
May 28, 2019 11:51AM
|
|
Re: Heartland's off-topic item on Agoracom...
|
1
|
Resverlogix Corp.
|
Oct 25, 2016 12:36PM
|
|
Re: Heart Failure
|
5
|
Resverlogix Corp.
|
Apr 07, 2020 09:08AM
|
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
7
|
Resverlogix Corp.
|
Apr 12, 2021 10:49AM
|
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
3
|
Resverlogix Corp.
|
Apr 12, 2021 10:54AM
|
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
18
|
Resverlogix Corp.
|
Apr 12, 2021 12:56PM
|
|
Re: HDL Functionality
|
4
|
Resverlogix Corp.
|
May 06, 2019 11:47AM
|
|
Re: HDL function is associated with atherosclerotic burden and cardiovascular outcomes in T2D
|
2
|
Resverlogix Corp.
|
Oct 16, 2018 06:45PM
|
|
Re: HDL from an Alzheimer's disease perspective
|
6
|
Resverlogix Corp.
|
Jun 27, 2019 01:08PM
|
|
Re: HDL from an Alzheimer's disease perspective
|
4
|
Resverlogix Corp.
|
Jun 27, 2019 10:08AM
|
|
Re: HDL from an Alzheimer's disease perspective
|
1
|
Resverlogix Corp.
|
Jun 27, 2019 10:22AM
|
